RUNX2 Antikörper (AA 264-279)
Kurzübersicht für RUNX2 Antikörper (AA 264-279) (ABIN2354898)
Target
Alle RUNX2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 264-279
-
Sequenz
- NPQGQSQITD PRQAQS
-
Kreuzreaktivität
- Huhn, Pferd, Human, Affe, Maus
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Ch Eq Hu Mk Mo
-
Produktmerkmale
- RUNX2 (Runt-related Transcription Factor 2, Acute Myeloid Leukemia 3 Protein, AML3, CCD, CCD1, Core-binding Factor Subunit alpha-1, CBF-alpha-1, CBFA1, Oncogene AML-3, Osteoblast-specific Transcription Factor 2, OSF2, OSF-2, Polyomavirus Enhancer-binding Protein 2 alpha A Subunit, PEA2-alpha A, PEA2aA, PEBP2-alpha A, PEBP2A, PEBP2aA, PEBP2aA1, PEBP2A1, PEBP2A2, SL3/AKV Core-binding Factor alpha A Subunit)
-
Aufreinigung
- Purified by Protein G affinity Chromatography.
-
Immunogen
- Synthetic peptide (NPQGQSQITDPRQAQS) corresponding to aa264-279 of human RUNX2.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.2 % gelatin, 0.05 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- RUNX2 (Runt-Related Transcription Factor 2 (RUNX2))
-
Andere Bezeichnung
- RUNX2
-
NCBI Accession
- NP_004339, NP_001019801
Target
-